Browse > Article
http://dx.doi.org/10.4489/MYCO.2006.34.3.143

Mycelial Extract of Phellinus linteus Induces Cell Death in A549 Lung Cancer Cells and Elevation of Nitric Oxide in Raw 264.7 Macrophage Cells  

Lee, Jong-Jin (Department of Bioscience & Biotechnology, Central Research Center, Whanin Pharm. Co., Ltd.)
Kwon, Ho-Kyun (Department of Bioscience & Biotechnology, Central Research Center, Whanin Pharm. Co., Ltd.)
Lee, Dong-Soo (Department of Bioscience & Biotechnology, Central Research Center, Whanin Pharm. Co., Ltd.)
Lee, Seung-Woo (Department of Bioscience & Biotechnology, Central Research Center, Whanin Pharm. Co., Ltd.)
Lee, Kye-Kwan (Department of Bioscience & Biotechnology, Central Research Center, Whanin Pharm. Co., Ltd.)
Kim, Kyu-Joong (Department of Biology, Kangnung National University)
Kim, Jong-Lae (Department of Bioscience & Biotechnology, Central Research Center, Whanin Pharm. Co., Ltd.)
Publication Information
Mycobiology / v.34, no.3, 2006 , pp. 143-147 More about this Journal
Abstract
In the present study, in order to investigate the anti-proliferative phenomenon of PLME, the effects of mycelial extract of Phellinus linteus (PLME) on the growth of human lung carcinoma cell line A549 was examined. We studied on the effects of PLME on the release of nitric oxide (NO) in mouse macrophage Raw 264.7 cells. Treatment of PLME to A549 cells resulted in the growth inhibition, morphological change and induction of apoptotic cell death in a dose-dependent manner as measured by MTT assay. We found that PLME stimulated a dose-dependent increase in NO production. These findings suggest that PLME enhances the anti-tumoral activity of macrophage and may be a potential therapeutic agent for the control of human lung carcinoma cells.
Keywords
A549; Nitric oxide; Phellinus linteus; PLME; Raw 264.7;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Duan, W., Yu, Y. and Zhang, L. 2005. Antiatherogenic effects of Phyllantus Emblica associated with Corilagin and its Analogue. Yakugaku Zasshi 5: 587-591
2 Duerksen-Hughes, P. J., Day, D., Laster, S. M., Zachariades, N. A., Aquino, L. and Gooding, L. R. 1992. Both tumor necrosis factor and nitric oxide participate in lysis of simian virus 40transformed cells by activated macrophages. J. Immunol. 149: 2114-2122
3 Bededovsky, H. O. and Del Rey, A. 1996. Immuno-neuro-endocrineinteractions: facts and hypotheses. Endocrine Review 17: 64-102   DOI
4 Bonomi, P., Kim, K., Fairclough, D., Cella, D., Kugler, J., Rowinsky, E., Jiroutek, M. and Johnson, D. 2000. Comparisons of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial. J. Clin. Oncol. 18: 623-631   DOI
5 Cardenal, F., Lopez-Cabrerizo, M. P., Anton, A., Alberola, V., Massuti, B., Carrato, A., Barneto, I., Lomas, M., Garcia, M., Lianes, P., Montalar, J., Vadell, C., Gonzalez-Larriba, J. L., Nguyen, B., Artal, A. and Rosell, R. 1999. Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cenacer. J. Clin. Oncol. 17: 12-18   DOI
6 Stuehr, D. J. and Nathan, C. F. 1989. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169: 1543-1555   DOI   ScienceOn
7 Eisenberg, D. M., Davis, R. B., Ettner, S. L., Wilkey, S., Van, Rompay. M. and Kessler, R. G 1998. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. J. Am. Med. Assoc. 280: 1569-1575   DOI   ScienceOn
8 Klostergaard, J. 1993. Macrophages tumoricial mechanism. Res. Immunol. 87: 581-586
9 Han, S. B., Lee, C. W., Jeon, Y. J., Hong, N. D., Yoo, I. D., Yang, K. H. and Kim, H. M. 1999. The inhibitory effect of polysaccharide isolated from Phellinus linteus on tumor growth and metastasis. Immunopharm. 41: 157-164   DOI   ScienceOn
10 Han, S. B., Lee, C. W., Jeon, Y. J., Hong, N. D., Yoo, I. D., Yang, K. H. and Kim, H. M. 1999. The inhibitory effect of polysaccharides isolated from Phellinus linteus on tumor growth and metastasis. Immunopharmacology 41: 157-164   DOI   ScienceOn
11 Lowenstein, C. J., Dinerman, J. L. and Snyder, S. H. 1994. Nitric oxide: A physiologic messenger. Annals Int. Medicine 120: 227-237   DOI   ScienceOn
12 Mountain, C. F. 1997. Revisions in the international system for staging lung cancer. Chest 111: 1710-1717   DOI   ScienceOn
13 Poderoso, J. J., Carreras, M. c., Schopfer, F., Lisdero, C. L., Riobo, N. A., Giulivi, C., Boveris, A. D., Boveris, A. and Cadenas, E. 1999. The reaction of nitric oxide with ubiquinol: kinetic properties and biological significance. Free Radical Biol. Medicine 26: 925-935   DOI   ScienceOn
14 Lorsbach, R. B., Murphy, W. J., Lowenstein, C. J., Snyder, S. H. and Russell, S. W. 1993. Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferon-gamma and lipopolysaccharide. J. Biol. Chem. 268: 1908-1913
15 Collins, L., Zhu, T., Guo, J., Xiao, Z. J. and Chen, C. Y. 2006. Phellinus linteus sensitizes apoptosis induced by doxorubicin in prostate cancer. British. J. Cancer. 95: 282-288   DOI   ScienceOn
16 Schiller, J. H., Harrington, D., Belani, C. P., Langer, C., Sandler, A., Krook, J., Zhu, J. and Johnson, D. H. 2002. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl. J. Med. 346: 92-98   DOI   ScienceOn
17 Moncada, S., Palmer, R. M. and Higgs, E. A. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43: 109-142
18 Flick, D. A. and Gifford, G E. 1984. Comparison of in vitro cell cytotoxicity assays for tumor necrosis factor. J. Immunol. 68: 167-175   DOI   ScienceOn
19 Van, F. R., Sluiter, W. V. and Dissel, J. T. 1986. Genetic control of monocyte production and macrophage function. In: Steinman, R. M. and North, R. J. (Eds.), Mechanisms of Host Resistance to Infectious Agents, Tumor, and Allografts. Rockeller Universiy, New York. 138
20 Wasser, S. P. 2002. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl. Microbial. Biotech. 60: 258-274   DOI
21 Fidler, I. J. and Kleinerman, E. S. 1993. Therapy of cancer metastasis by systemic activation of macrophages; from bench to the clinic. Res. Immunol. 144: 274-276   DOI   ScienceOn